Table 1.

Patient demographics and disease activity measures

Patient number	Sex	Race	Age (Years)	HLA-B27	BASDAI	ESR (mm/h)	CRP (mg/dl)	Anti-TNF therapy
1	F	W	48	+	1	14	0.5	+
2	M	H	52	−	3.7	7	0.5	+
3	F	W	47	+	3.85	53	0.5
4	M	W	62	−	7.6	—	—	+
5	M	W	66	+	1	1	0.6
6	M	W	53	−	4.5	19	0.5
7	M	B	53	+	6.8	10	2.2
8	M	W	56	+	4.6	23	1.4
9	M	B	44	−	7.9	47	1.2
10	M	W	33	+	8.1	25	1.1	+
11	F	W	22	+	5.8	1	0.5
12	F	B	59	+	7.4	48	0.5	+
13	F	B	44	+	5.7	31	0.5
14	M	W	42	−	7.1	11	0.5
15	F	W	53	−	5.1	7	0.6	+